Emcure Pharmaceuticals
EMCURE · Pharma > Pharmaceuticals & Drugs Listing date: July 10, 2024

Stock Price vs Company Growth
1d
0.5%
1w
5.7%
1m
5.6%
3m
8.7%
6m
28.1%
1y
29.6%
all
16.9%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,883 0.5%
1,668
2,047
Company Overview

Sales
9,683 Cr
Growth: 15.9%
Profit after Tax
1,001 Cr
Growth: 9.5%
Large Cap
35,721 Cr
P/E: 35.3x
Industry P/E: 31.7x
Fundamentals

Sales (Cr) ₹ 9,683
Growth 15.9%
EBITDA 20.1%
P/S 3.7x
Dividend 0.2%
P/E 35.3x
Book Value ₹ 276
PEG Ratio 2.2x
ROE 19.8%
P/B 6.8x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company’s core strength and competitive advantage lie in its established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS (Central Nervous System) & HIV (Human Immunodeficiency Virus) among others.
Followers (1)